PeterSKleinMD
Hematology • Philadelphia, PAAssociate Professor, Medicine, Perelman School of Medicine
Are you Dr. Klein?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 66 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
# 15
Philadelphia, PA 19104Phone+1 215-662-3914
Summary
- Dr. Peter Klein, MD is a hematologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with Hospital of the University of Pennsylvania and is an Associate Professor at Perelman School of Medicine.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2000 - 2005
Massachusetts General HospitalResidency, Internal Medicine, 1988 - 1991
Johns Hopkins University School of MedicineClass of 1988
Certifications & Licensure
PA State Medical License 1995 - 2024
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 2003
- Investigator Alumnus Howard Hughes Medical Institute, 1995
Publications & Presentations
PubMed
- 26 citationsChromatin accessibility and histone acetylation in the regulation of competence in early development.Melody Esmaeili, Shelby A. Blythe, John W. Tobias, Kai Zhang, Jing Yang
Developmental Biology. 2020-06-01 - 1690 citationsGuidelines for the use and interpretation of assays for monitoring autophagy (4th edition)Daniel J. Klionsky, Amal Kamal Abdel-Aziz, Sara Abdelfatah, Mahmoud Abdellatif, Asghar Abdoli
Autophagy. 2021-02-08 - 1933 citationsA molecular mechanism for the effect of lithium on developmentPeter S. Klein, Douglas A. Melton
Proceedings of the National Academy of Sciences of the United States of America. 1996-08-06
Grant Support
- Targeting WNT And Mtor To Expand Hematopoietic Stem CellsNational Heart, Lung, And Blood Institute2011–2012
- Regulating Hematopoietic Stem Cell Homeostasis Through GSK-3National Heart, Lung, And Blood Institute2011–2012
- A Molecular Mechanism For Lithium ActionNational Institute Of Mental Health2001–2010
- Early Activation Of The Zygotic GenomeNational Institute Of General Medical Sciences2006–2009
- Phase II Trial Of Valproic Acid In MyelodysplasiaNational Cancer Institute2005–2006
- A Novel Molecular Target Of Valproic AcidNational Institute Of Mental Health2002–2006
- Molecular Mechanism For Lithium ActionNational Institute Of Mental Health1998–2000
- Molecular Target Of Lithium In Affective DisordersNational Institute Of Mental Health1997–1998
